Back to Search
Start Over
Concomitant ALK translocation and EGFR C797S mutation as resistance mechanisms to osimertinib in an EGFR-mutant NSCLC patient.
- Source :
-
Respiratory medicine and research [Respir Med Res] 2024 May 14; Vol. 86, pp. 101116. Date of Electronic Publication: 2024 May 14. - Publication Year :
- 2024
- Publisher :
- Ahead of Print
-
Abstract
- Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Details
- Language :
- English
- ISSN :
- 2590-0412
- Volume :
- 86
- Database :
- MEDLINE
- Journal :
- Respiratory medicine and research
- Publication Type :
- Academic Journal
- Accession number :
- 38843599
- Full Text :
- https://doi.org/10.1016/j.resmer.2024.101116